Federica O’Brien
Director/Board Member bij TELA BIO, INC.
Vermogen: 42 385 $ op 29-02-2024
Profiel
Presently, Federica O’Brien occupies the position of President for CFO'Brien Consulting LLC.
Ms. O’Brien is also on the board of TELA Bio, Inc. and MacroGenics, Inc.
In her past career Ms. O’Brien was Chief Financial Officer for Complexa, Inc., Chief Financial Officer, Secretary & Treasurer for Avalo Therapeutics, Inc., Director-Life Sciences at RSM US LLP and Director-Life Sciences at RSM McGladrey, Inc. (a subsidiary of RSM US LLP), Controller & Director-Financial Reporting at Tucows, Inc., Chief Financial & Operating Officer at Lucina Health, Inc., Chief Financial Officer & Vice President-Finance for CardioKine, Inc., Controller at Barrier Therapeutics, Inc. and Audit Manager at Coopers & Lybrand LLP.
Ms. O’Brien received an undergraduate degree from Rutgers State University of New Jersey.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
TELA BIO, INC.
0.03% | 01-06-2023 | 6 270 ( 0.03% ) | 42 385 $ | 29-02-2024 |
MACROGENICS, INC.
-.--% | 31-05-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Federica O’Brien
Bedrijven | Functie | Begin |
---|---|---|
TELA BIO, INC. | Director/Board Member | 13-11-2019 |
MACROGENICS, INC. | Director/Board Member | 10-02-2021 |
CFO'Brien Consulting LLC | President | 01-01-2018 |
Eerdere bekende functies van Federica O’Brien
Bedrijven | Functie | Einde |
---|---|---|
GT BIOPHARMA, INC. | Director/Board Member | 02-07-2018 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Director of Finance/CFO | 01-12-2017 |
AVALO THERAPEUTICS, INC. | Director of Finance/CFO | 01-05-2015 |
Lucina Health, Inc.
Lucina Health, Inc. Electronic Equipment/InstrumentsElectronic Technology Lucina Health, Inc. engages in the provision of maternity analytics platform solutions. It focuses on women at-risk of preterm birth. The company was founded by Michael G. Ross, Rosalyn P. Baxter-Jones, Kevin L. Bramer, and Dean Koch in 2008 and is headquartered in Louisville, KY. | Director of Finance/CFO | 01-04-2013 |
RSM US LLP
RSM US LLP Miscellaneous Commercial ServicesCommercial Services RSM US LLP engages in the provision of accounting services. It offers audit, tax, consulting, and wealth management services. The firm serves the energy, government, life sciences, manufacturing, private equity, and real estate and construction industries. The company was founded by Ira B. McGladrey in 1926 and is headquartered in Chicago, IL. | Corporate Officer/Principal | 01-05-2011 |
Opleiding van Federica O’Brien
Rutgers State University of New Jersey | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
GT BIOPHARMA, INC. | Health Technology |
TUCOWS INC. | Technology Services |
TELA BIO, INC. | Health Technology |
MACROGENICS, INC. | Health Technology |
AVALO THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Coopers & Lybrand LLP | Commercial Services |
RSM US LLP
RSM US LLP Miscellaneous Commercial ServicesCommercial Services RSM US LLP engages in the provision of accounting services. It offers audit, tax, consulting, and wealth management services. The firm serves the energy, government, life sciences, manufacturing, private equity, and real estate and construction industries. The company was founded by Ira B. McGladrey in 1926 and is headquartered in Chicago, IL. | Commercial Services |
RSM McGladrey, Inc.
RSM McGladrey, Inc. Miscellaneous Commercial ServicesCommercial Services RSM McGladrey, Inc. provides financial services. It offers audit, tax, consulting, financial advisory, risk advisory, technology and management, transaction advisory, wealth management. The company was founded by George Hansen and Keith Dunn in 1926 and is headquartered in Minneapolis, MN. | Commercial Services |
Lucina Health, Inc.
Lucina Health, Inc. Electronic Equipment/InstrumentsElectronic Technology Lucina Health, Inc. engages in the provision of maternity analytics platform solutions. It focuses on women at-risk of preterm birth. The company was founded by Michael G. Ross, Rosalyn P. Baxter-Jones, Kevin L. Bramer, and Dean Koch in 2008 and is headquartered in Louisville, KY. | Electronic Technology |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
CFO'Brien Consulting LLC |